Edition:
United States

Codexis Inc (CDXS.OQ)

CDXS.OQ on NASDAQ Stock Exchange Global Select Market

15.20USD
4:00pm EDT
Change (% chg)

$-0.25 (-1.62%)
Prev Close
$15.45
Open
$15.35
Day's High
$15.70
Day's Low
$15.15
Volume
61,007
Avg. Vol
86,646
52-wk High
$16.75
52-wk Low
$5.15

Latest Key Developments (Source: Significant Developments)

Porton Fine Chemicals signs strategic agreement with Codexis on enzymatic related business
Wednesday, 25 Apr 2018 07:54am EDT 

April 25 (Reuters) - Porton Fine Chemicals Ltd <300363.SZ> ::Says it signed strategic agreement with U.S. company Codexis Inc <<>> on enzymatic related business .  Full Article

Codexis Announces Pricing Of Public Offering Of Common Stock
Thursday, 5 Apr 2018 09:15pm EDT 

April 6 (Reuters) - Codexis Inc ::CODEXIS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 3.75 MILLION COMMON SHARES PRICED AT $9.25PER SHARE.  Full Article

Codexis Q4 Non-Gaap Earnings Per Share $0.06
Thursday, 8 Mar 2018 04:05pm EST 

March 8 (Reuters) - Codexis Inc ::CODEXIS REPORTS 2017 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS.Q4 NON-GAAP EARNINGS PER SHARE $0.06.Q4 EARNINGS PER SHARE $0.02.Q4 EARNINGS PER SHARE VIEW $0.05 -- THOMSON REUTERS I/B/E/S.SEES FY 2018 REVENUE $60 MILLION TO $63 MILLION.‍TOTAL REVENUES FOR Q4 OF 2017 INCREASED 118% TO $21.7 MILLION FROM $10.0 MILLION FOR Q4 OF 2016​.SEES ‍ 2018 PRODUCT SALES ARE EXPECTED TO BE $25 MILLION TO $28 MILLION​.SEES ‍2018 GROSS MARGIN ON PRODUCT SALES IS EXPECTED TO BE 45% TO 48%​.FY2018 REVENUE VIEW $68.6 MILLION -- THOMSON REUTERS I/B/E/S.Q4 REVENUE VIEW $23.0 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Telemark Asset Management LLC reports 6.72 pct passive stake in Codexis ‍​as of Nov 10
Monday, 20 Nov 2017 05:51pm EST 

Nov 20 (Reuters) - Codexis Inc :Telemark Asset Management LLC reports 6.72 percent passive stake in Codexis Inc ‍​as of November 10 - SEC Filing.  Full Article

Codexis Q3 non-gaap loss per share $0.17
Thursday, 9 Nov 2017 04:05pm EST 

Nov 9 (Reuters) - Codexis Inc ::Codexis reports financial results for the third quarter of 2017.Q3 non-gaap loss per share $0.17.Q3 loss per share $0.21.Sees FY 2017 revenue $50 million to $53 million.Q3 earnings per share view $-0.17 -- Thomson Reuters I/B/E/S.Codexis Inc - ‍total revenues for Q3 of 2017 were $10.0 million compared with $14.9 million for q3 of 2016​.Codexis Inc - ‍gross margin on product sales is expected to be between 40% and 43% for 2017​.  Full Article

Codexis Inc, Nestlé Health Science enter strategic collaboration​
Thursday, 12 Oct 2017 08:00am EDT 

Oct 12 (Reuters) - Codexis Inc :Codexis Inc - ‍co, Nestlé Health Science enter strategic collaboration​.Codexis Inc - ‍Codexis receives an upfront payment of $14 million and potential milestones and royalties depending on product success for deal​.Codexis Inc - deal ‍includes an option for global development of CDX-6114 for PKU​.Codexis Inc - ‍Codexis will be responsible for clinical development costs for CDX-6114 up to and including Phase 1 in healthy volunteers​.Codexis - after ‍phase 1, Nestlé health science will have option to obtain exclusive global license to CDX-6114.Codexis - after ‍Phase 1, Nestlé health science will be responsible for all future development and commercialization of CDX-6114​.  Full Article

Codexis Q2 loss per share $0.13
Wednesday, 9 Aug 2017 04:05pm EDT 

Aug 9 (Reuters) - Codexis Inc :Codexis reports financial results for the second quarter of 2017.Q2 non-GAAP loss per share $0.09.Q2 loss per share $0.13.Q2 earnings per share view $-0.13 -- Thomson Reuters I/B/E/S.Codexis Inc - total revenues for Q2 of 2017 were $10.3 million compared with $16.0 million for Q2 of 2016.Codexis Inc - affirms 2017 total revenue guidance.Codexis Inc - increases full year product sales and gross margin guidance.Sees 2017 product sales guidance of between $25 million and $27 million reflects an increase of 63% to 76% over 2016.Codexis Inc - increasing guidance of product gross margin to between 40% and 43% for 2017.  Full Article

Codexis ‍wins summary judgment of patent infringement against EnzymeWorks​
Tuesday, 8 Aug 2017 04:38pm EDT 

Aug 9 (Reuters) - Codexis Inc -:Codexis Inc - ‍obtains court order awarding summary judgment of patent infringement against EnzymeWorks​.Codexis Inc - ‍secured federal court order awarding co summary judgment on 10 claims of patent infringement brought in lawsuit against EnzymeWorks Inc​.  Full Article

Codexis, effective as of June 30, entered into loan, security agreement with Western Alliance Bank
Friday, 7 Jul 2017 04:25pm EDT 

July 7 (Reuters) - Codexis Inc ::Codexis Inc - effective as of june 30, 2017 co entered into a loan and security agreement with western alliance bank.Codexis Inc - pursuant to agreement wab agreed to make term loans available to company in a principal amount of up to $10 million - sec filing.Codexis - WAB agreed to make revolving advances available to co in principal amount of up to $5 million, with accounts receivable borrowing base of 80% of eligible accounts.Codexis Inc - company did not draw from credit facility on closing date, and term loans may be funded at company's request prior to june 30, 2018.  Full Article

Codexis reports Q1 non-GAAP loss per share $0.13
Tuesday, 9 May 2017 04:05pm EDT 

May 9 (Reuters) - Codexis Inc :Codexis reports financial results for the first quarter of 2017.Q1 non-GAAP loss per share $0.13.Q1 loss per share $0.18.Q1 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S.Codexis Inc says Codexis is affirming its financial guidance for 2017.FY 2017 earnings per share view $-0.31, revenue view $51.3 million -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Codexis Reports Q1 Loss Per Share $0.10

* Q1 EARNINGS PER SHARE VIEW $-0.12 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage: